SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDVO.L Regulatory News (DVO)

  • There is currently no data for DVO

Interim Management Statement

14 Nov 2013 07:00

RNS Number : 9770S
Devro PLC
14 November 2013
 



For immediate release

14 November 2013

 

 

Devro plc

("the Group")

 

Interim Management Statement

 

Devro plc, one of the world's leading manufacturers of collagen products for the food industry, today provides an Interim Management Statement covering the period from 1 July 2013 to date.

 

Revenue continued to grow helped by the full impact of price increases implemented in the first half with sales volumes unchanged against the same period last year. Trading profits and margins have improved in the second half as new capacity at the Czech plant has come on stream.

Sales have been strong in emerging markets, most notably Latin America, China and South East Asia. Germany and Japan continued to grow volumes across all major product categories. Developed markets such as the UK, continental Europe, Australia and North America traded more slowly than prior year and below our expectations.

Select, the innovative thin walled casing introduced in 2010 to replace top quality sheep gut, continues to make a significant contribution to sales. In the year to date Select accounts for 8% of all sales in the Group. There continue to be good opportunities for new sales.

Manufacturing operations ran well with the investment at the Czech plant now complete and production at full capacity.

The Board has approved capital expenditure to construct a new manufacturing hall at our site in South Carolina, USA. This £40m project, which will be funded from the Group's existing facilities and future cash flow, will enable the business to reduce manufacturing costs by c.£8m pa from 2016 onwards, with full benefits expected in 2017. This investment is part of our continuing manufacturing improvement programme which will further enhance profits for sales into the Americas.

As mentioned at the interims, the Group is actively evaluating options for expansion of capacity through an investment in China and we expect to report on this in early 2014.

Hide prices are higher than the prior year although the rate of increase has significantly slowed compared with the increases experienced in the last 18 months.

The Japanese yen has devalued by 20% against prior year although the impact on 2013 has been minimised through forward hedging. In 2014, based on current exchange rates, we estimate that profits will be adversely affected by approximately £3m as current hedging arrangements unwind.

Gross debt is broadly in line with the level at the half year and continues to be well within the banking facilities.

 

Outlook

 

In light of unchanged sales volumes and weakness in some developed markets since 1st July, the Board now expects the outcome for 2013 to be towards the lower end of market expectations.

 

The Board remains confident in the longer term opportunities for supplying a dynamic and growing global market for edible casings.

 

For further information, please contact:

Devro plc

 

Peter Page, Chief Executive

Simon Webb, Group Finance Director

 

Tel No: 0207 182 4960

 

Buchanan

 

Charles Ryland / Sophie McNulty / Clare Akhurst

 

 

Tel No: 020 7466 5000

Further information on Devro can be found on the company's website: www.devro.com

As previously announced, Devro will be holding an investor presentation to provide an update on the Group's investment programme today at 4.00pm. The presentation will be available on the company's website shortly thereafter. No new material information will be disclosed during the presentation.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSZMMMMNFZGFZM
Date   Source Headline
1st Apr 20221:00 pmRNSBlock Listing Application
31st Mar 20229:57 amRNSDirector/PDMR Shareholding
25th Mar 20223:51 pmRNSAnnual Report & Accounts 2021 & Notice of 2022 AGM
2nd Mar 20227:00 amRNSFULL YEAR RESULTS
21st Jan 20223:17 pmRNSDirector/PDMR Shareholding
20th Jan 20225:39 pmRNSDirector/PDMR Shareholding
19th Jan 20225:23 pmRNSDirector/PDMR Shareholding
19th Jan 20227:00 amRNSTrading update
16th Dec 202112:14 pmRNSHolding(s) in Company
23rd Nov 20217:00 amRNSTrading Update
2nd Nov 20217:00 amRNSDirectorate Changes
29th Sep 20218:00 amRNSNotice of ESG Seminar
24th Aug 20218:48 amRNSHolding(s) in Company
24th Aug 20218:47 amRNSHolding(s) in Company
12th Aug 20215:55 pmRNSHolding(s) in Company
4th Aug 202111:19 amRNSDirector/PDMR Shareholding
29th Jul 20217:00 amRNSHalf-year Results
27th Jul 20214:57 pmRNSDirector/PDMR Shareholding
4th Jun 20219:05 amRNSDirector Declaration
5th May 20215:15 pmRNSDirector/PDMR Shareholding
4th May 20215:34 pmRNSDirector/PDMR Shareholding
29th Apr 20215:09 pmRNSResult of AGM
29th Apr 20217:00 amRNSTrading Update
15th Apr 20213:14 pmRNSDirector/PDMR Shareholding
13th Apr 20214:53 pmRNSDirector/PDMR Shareholding
26th Mar 20214:47 pmRNS2020 Annual Report and Notice of AGM
10th Mar 20215:04 pmRNSDirector/PDMR Shareholding
5th Mar 20214:45 pmRNSDirector/PDMR Shareholding
2nd Mar 20217:00 amRNSFULL YEAR RESULTS
20th Jan 20219:29 amRNSDirector/PDMR Shareholding
18th Jan 20217:00 amRNSTrading update
18th Dec 20202:12 pmRNSDirector/PDMR Shareholding
24th Nov 20207:00 amRNSTrading Update
22nd Oct 20207:00 amRNSDirectorate Changes
14th Oct 20207:00 amRNSDirectorate Appointment
7th Oct 202010:16 amRNSDirector/PDMR Shareholding
17th Aug 20207:00 amRNSDirector/PDMR Shareholding
29th Jul 20207:01 amRNSDirectorate Change
29th Jul 20207:00 amRNSHALF YEAR RESULTS
30th Jun 20207:00 amRNSAppointment of Corporate Broker
23rd Jun 20209:23 amRNSHolding(s) in Company
12th Jun 20208:27 amRNSDirector/PDMR Shareholding
15th May 202012:02 pmRNSPrice Monitoring Extension
12th May 202011:06 amRNSDirector/PDMR Shareholding
30th Apr 20202:39 pmRNSResult of AGM
29th Apr 20207:00 amRNSDirectorate Appointment
27th Apr 20204:54 pmRNSPublication of Articles of Association
27th Apr 20209:33 amRNSDirector/PDMR Shareholding
23rd Apr 20207:00 amRNSTrading Update
16th Apr 20204:59 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.